Found: 2

Select item for more details and to access through your institution.

  • Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38886-8
    By:
    • DeMartino, Jeff;
    • Meister, Michael T.;
    • Visser, Lindy L.;
    • Brok, Mariël;
    • Groot Koerkamp, Marian J. A.;
    • Wezenaar, Amber K. L.;
    • Hiemcke-Jiwa, Laura S.;
    • de Souza, Terezinha;
    • Merks, Johannes H. M.;
    • Rios, Anne C.;
    • Holstege, Frank C. P.;
    • Margaritis, Thanasis;
    • Drost, Jarno
    Publication type:
    Article

  • Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 10, p. 1, doi. 10.15252/emmm.202216001
    By:
    • Meister, Michael T;
    • Groot Koerkamp, Marian J A;
    • de Souza, Terezinha;
    • Breunis, Willemijn B;
    • Frazer‐Mendelewska, Ewa;
    • Brok, Mariël;
    • DeMartino, Jeff;
    • Manders, Freek;
    • Calandrini, Camilla;
    • Kerstens, Hinri H D;
    • Janse, Alex;
    • Dolman, M Emmy M;
    • Eising, Selma;
    • Langenberg, Karin P S;
    • van Tuil, Marc;
    • Knops, Rutger R G;
    • van Scheltinga, Sheila Terwisscha;
    • Hiemcke‐Jiwa, Laura S;
    • Flucke, Uta;
    • Merks, Johannes H M
    Publication type:
    Article